Skip to main content
Log in

CIRSE Standards of Practice on Thermal Ablation of Liver Tumours

  • CIRSE Standards of Practice
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

Abstract

This CIRSE Standards of Practice document reviews current literature and provides best practices for image guided thermal ablation of liver tumours, including radiofrequency, microwave and cryoablation techniques.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ahmed M, Solbiati L, Brace CL, Breen DJ, Callstrom, Charboneau JW, et al. International Working Group on Image-Guided Tumor Ablation, Interventional Oncology Sans Frontières Expert Panel, Technology Assessment Committee of the Society of Interventional Radiology, Standard of Practice Committee of the Cardiovascular and Interventional Radiological Society of Europe, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria—a 10-year update. J Vasc Interv Radiol. 2014;25(11):1691–705.

  2. Wang X, Sofocleous CT, Erinjeri JP, Petre EN, Gonen M, Do KG, et al. Margin size is an independent predictor of local tumor progression after ablation of colon cancer liver metastases. Cardiovasc Interv Radiol. 2013;36(1):166–75.

    Article  CAS  Google Scholar 

  3. Kim YS, Lee WJ, Rhim H, Lim HK, Choi D, Lee JY. The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion. AJR Am J Roentgenol. 2010;195(3):758–65.

    Article  PubMed  Google Scholar 

  4. Filippiadis DK, Binkert C, Pellerin O, Hoffmann RT, Krajina A, Pereira PL. CIRSE quality assurance document and standards for classification of complications: the CIRSE classification system. Cardiovasc Interv Radiol. 2017;40(8):1141–6.

    Article  CAS  Google Scholar 

  5. Crocetti L, de Baere T, Lencioni R. Quality improvement guidelines for radiofrequency ablation of liver tumours. Cardiovasc Interv Radiol. 2010;33(1):11–7.

    Article  Google Scholar 

  6. American College of Radiology https://www.acr.org/Clinical-Resources/Reporting-and-Data-Systems/LI-RADS/CT-MRI-LI-RADS-v2018 (2018). Accessed 3 Jan 2020.

  7. American College of Radiology https://www.acr.org/Clinical-Resources/Reporting-and-Data-Systems/LI-RADS/CEUS-LI-RADS-v2017 (2017). Accessed 3 Jan 2020.

  8. Vreugdenburg TD, Ma N, Duncan JK, Riitano D, Cameron AL, Maddern GJ. Comparative diagnostic accuracy of hepatocyte-specific gadoxetic acid (Gd-EOB-DTPA) enhanced MR imaging and contrast enhanced CT for the detection of liver metastases: a systematic review and meta analysis. Int J Colorectal Dis. 2016;31(11):1739–49.

    Article  PubMed  Google Scholar 

  9. Bridgewater J, Galle PR, Khan SA, Llovet JM, Park JW, Patel T, et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol. 2014;60(6):1268–89.

    Article  PubMed  Google Scholar 

  10. Pavel M, Baudin E, Couvelard A, Krenning E, Öberg K, Steinmüller T, Barcelona Consensus Conference participants, et al. ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary. Neuroendocrinology. 2012;95(2):157–76.

    Article  CAS  PubMed  Google Scholar 

  11. Senkus E, Kyriakides S, Ohno S, Penault-Llorca F, Poortmans P, Rutgers E, ESMO Guidelines Committee, et al. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26(Suppl 5):v8–30.

    Article  PubMed  Google Scholar 

  12. Pacini F, Castagna MG, Brilli L, Pentheroudakis G, ESMO Guidelines Working Group. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012;23(Suppl 7):vii110–9.

    Article  PubMed  Google Scholar 

  13. Dummer R, Hauschild A, Lindenblatt N, Pentheroudakis G, Keilholz U, ESMO Guidelines Committee. Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26(Suppl 5):v126–32.

    Article  PubMed  Google Scholar 

  14. Crocetti L, Iezzi R, Goldberg SN, Bilbao JI, Sami A, Akhan O, et al. The ten commandments of liver ablation: expert discussion and report from Mediterranean Interventional Oncology (MIOLive) congress 2017. Eur Rev Med Pharmacol Sci. 2018;22(12):3896–904.

    CAS  PubMed  Google Scholar 

  15. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182–236.

    Article  Google Scholar 

  16. Agopian VG, Harlander-Locke MP, Ruiz RM, Klintmalm GB, Senguttuvan S, Florman SS, et al. Impact of pretransplant bridging locoregional therapy for patients with hepatocellular carcinoma within milan criteria undergoing liver transplantation: analysis of 3601 patients from the US multicenter HCC transplant consortium. Ann Surg. 2017;266(3):525–35.

    Article  PubMed  Google Scholar 

  17. Van Cutsem E, Cervantes A, Adam R, Sobrero A, Van Krieken JH, Aderka D, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol. 2016;27(8):1386–422.

    Article  PubMed  Google Scholar 

  18. Clavien PA, Petrowsky H, DeOliveira ML, Graf R. Strategies for safer liver surgery and partial liver transplantation. N Engl J Med. 2007;356(15):1545–59.

    Article  PubMed  Google Scholar 

  19. Solbiati L, Ahmed M, Cova L, Ierace T, Brioschi M, Goldberg SN. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up. Radiology. 2012;265(3):958–68.

    Article  PubMed  Google Scholar 

  20. Weiser MR, Jarnagin WR, Saltz LB. Colorectal cancer patients with oligometastatic liver disease: What is the optimal approach? Oncology. 2013;27(11):1074–8.

    PubMed  Google Scholar 

  21. Ruers T, Van Coevorden F, Punt CJ, Pierie JE, Borel-Rinkes I, Ledermann JA, European Organisation for Research and Treatment of Cancer (EORTC), Gastro-Intestinal Tract Cancer Group; Arbeitsgruppe Lebermetastasen und tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie (ALM-CAO), National Cancer Research Institute Colorectal Clinical Study Group (NCRI CCSG), et al. Local treatment of unresectable colorectal liver metastases: results of a randomized phase II trial. J Natl Cancer Inst. 2017;109(9):djx015.

    Article  PubMed Central  Google Scholar 

  22. Sofocleous CT, Petre EN, Gonen M, Brown KT, Solomon SB, Covey AM, et al. CT-guided radiofrequency ablation as a salvage treatment of colorectal cancer hepatic metastases developing after hepatectomy. J Vasc Interv Radiol. 2011;22(6):755–61.

    Article  PubMed  PubMed Central  Google Scholar 

  23. de Baere T, Deschamps F, Tselikas L, Ducreux M, Planchard D, Pearson E, et al. GEP-NETS update: interventional radiology: role in the treatment of liver metastases from GEP-NETs. Eur J Endocrinol. 2015;172(4):R151–66.

    Article  PubMed  CAS  Google Scholar 

  24. Wettstein M, Vogt C, Cohnen M, Brill N, Kurz AK, Mödder U, et al. Serotonin release during percutaneous radiofrequency ablation in a patient with symptomatic liver metastases of a neuroendocrine tumor. Hepatogastroenterology. 2004;51:830–2.

    PubMed  Google Scholar 

  25. Bale R, Schullian P, Schmuth M, Widmann G, Jaschke W, Weinlich G. Stereotactic radiofrequency ablation for metastatic melanoma to the liver. Cardiovasc Interv Radiol. 2016;39(8):1128–35.

    Article  Google Scholar 

  26. Barral M, Auperin A, Hakime A, Cartier V, Tacher V, Otmezguine Y, et al. Percutaneous thermal ablation of breast cancer metastases in oligometastatic patients. Cardiovasc Interv Radiol. 2016;39(6):885–93.

    Article  CAS  Google Scholar 

  27. Mariani P, Almubarak MM, Kollen M, Wagner M, Plancher C, Audollent R, et al. Radiofrequency ablation and surgical resection of liver metastases from uveal melanoma. Eur J Surg Oncol. 2016;42(5):706–12.

    Article  CAS  PubMed  Google Scholar 

  28. Cazzato RL, Garnon J, Koch G, Shaygi B, Tsoumakidou G, Caudrelier J, et al. Current role of interventional radiology in the management of visceral and bone metastases from thyroid cancer. Gland Surg. 2018;7(2):80–8.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Patel IJ, Rahim S, Davidson JC, Hanks SE, Tam AL, Walker TG, et al. Society of interventional radiology consensus guidelines for the periprocedural management of thrombotic and bleeding risk in patients undergoing percutaneous image-guided interventions-part II: recommendations: endorsed by the Canadian Association for Interventional Radiology and the Cardiovascular and Interventional Radiological Society of Europe. J Vasc Interv Radiol. 2019;30(8):1168–84.

    Article  PubMed  Google Scholar 

  30. Veltri A, Bargellini I, Giorgi L, Almeida PAMS, Akhan O. CIRSE guidelines on percutaneous needle biopsy (PNB). Cardiovasc Interv Radiol. 2017;40(10):1501–13.

    Article  Google Scholar 

  31. Sutcliffe JA, Briggs JH, Little MW, McCarthy E, Wigham A, Bratby M, et al. Antibiotics in interventional radiology. Clin Radiol. 2015;70:223–34.

    Article  CAS  PubMed  Google Scholar 

  32. Chehab MA, Thakor AS, Tulin-Silver S, Connolly BL, Cahill AM, Ward TJ, et al. Adult and pediatric antibiotic prophylaxis during vascular and IR procedures: a Society of Interventional Radiology Practice Parameter Update Endorsed by the Cardiovascular and Interventional Radiological Society of Europe and the Canadian Association for Interventional Radiology. J Vasc Interv Radiol. 2018;29(11):1483–501.

    Article  PubMed  Google Scholar 

  33. Hoffmann R, Rempp H, Schmidt D, Pereira PL, Claussen CD, Clasen S. Prolonged antibiotic prophylaxis in patients with bilioenteric anastomosis undergoing percutaneous radiofrequency ablation. J Vasc Interv Radiol. 2012;23(4):545–51.

    Article  PubMed  Google Scholar 

  34. Lee MJ, Fanelli F, Haage P, Hausegger K, Van Lienden KP. Patient safety in interventional radiology: a CIRSE IR checklist. Cardiovasc Interv Radiol. 2012;35(2):244–6.

    Article  CAS  Google Scholar 

  35. ASA House of Delegates/Executive Committee www.asahq.org/standards-and-guidelines/asa-physical-status-classification-system (2014). Accessed 3 Jan 2020.

  36. Pereira PL, Trübenbach J, Schenk M, Subke J, Kroeber S, Schaefer I, et al. Radiofrequency ablation: in vivo comparison of four commercially available devices in pig livers. Radiology. 2004;232(2):482–90.

    Article  PubMed  Google Scholar 

  37. Hoffmann R, Rempp H, Erhard L, Blumenstock G, Pereira PL, Claussen CD, et al. Comparison of four microwave ablation devices: an experimental study in ex vivo bovine liver. Radiology. 2013;268(1):89–97.

    Article  PubMed  Google Scholar 

  38. Hinshaw JL, Lubner MG, Ziemlewicz TJ, Lee FT Jr, Brace CL. Percutaneous tumor ablation tools: microwave, radiofrequency, or cryoablation—What should you use and why? Radiographics. 2014;34(5):1344–62.

    Article  PubMed  Google Scholar 

  39. Crocetti L, Della Pina C, Cioni D, Lencioni R. Peri-intraprocedural imaging: US, CT, and MRI. Abdom Imaging. 2011;36(6):648–60.

    Article  PubMed  Google Scholar 

  40. De Baère T. Computed Tomography Imaging for Tumor Ablation. In: van Sonnenberg E, McMullen WN, Solbiati L, Livraghi T, Müeller PR, Silverman SG, editors. Tumor ablation. New York: Springer; 2005. p. 104–20.

    Chapter  Google Scholar 

  41. Clasen S, Rempp H, Hoffmann R, Graf H, Pereira PL, Claussen CD. Image-guided radiofrequency ablation of hepatocellular carcinoma (HCC): is MR guidance more effective than CT guidance? Eur J Radiol. 2014;83(1):111–6.

    Article  PubMed  Google Scholar 

  42. Ryan ER, Sofocleous CT, Schöder H, Carrasquillo JA, Nehmeh S, Larson SM, et al. Split-dose technique for FDG PET/CT-guided percutaneous ablation: a method to facilitate lesion targeting and to provide immediate assessment of treatment effectiveness. Radiology. 2013;268(1):288–95.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Vitale A, Peck-Radosavljevic M, Giannini EG, Vibert E, Sieghart W, Van Poucke S, et al. Personalized treatment of patients with very early hepatocellular carcinoma. J Hepatol. 2017;66(2):412–23.

    Article  PubMed  Google Scholar 

  44. Garnon J, Cazzato RL, Caudrelier J, Nouri-Neuville M, Rao P, Boatta E, et al. Adjunctive thermoprotection during percutaneous thermal ablation procedures: review of current techniques. Cardiovasc Interv Radiol. 2019;42(3):344–57.

    Article  Google Scholar 

  45. Saviano A, Iezzi R, Giuliante F, Salvatore L, Mele C, Posa A, Hepato CATT Study Group, et al. Liver resection versus radiofrequency ablation plus transcatheter arterial chemoembolization in cirrhotic patients with solitary large hepatocellular carcinoma. J Vasc Interv Radiol. 2017;28(11):1512–9.

    Article  PubMed  Google Scholar 

  46. Lu Z, Wen F, Guo Q, Liang H, Mao X, Sun H. Radiofrequency ablation plus chemoembolization versus radiofrequency ablation alone for hepatocellular carcinoma: a meta-analysis of randomized-controlled trials. Eur J Gastroenterol Hepatol. 2013;25(2):187–94.

    Article  CAS  PubMed  Google Scholar 

  47. Wang Y, Deng T, Zeng L, Chen W. Efficacy and safety of radiofrequency ablation and transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma: a meta analysis. Hepatol Res. 2016;46(1):58–71.

    Article  PubMed  Google Scholar 

  48. Smolock AR, Cristescu MM, Hinshaw A, Woo KM, Wells SA, Ziemlewicz TJ, et al. Combination transarterial chemoembolization and microwave ablation improves local tumor control for 3- to 5-cm hepatocellular carcinoma when compared with transarterial chemoembolization alone. Abdom Radiol. 2018;43(9):2497–504.

    Article  Google Scholar 

  49. Iezzi R, Pompili M, La Torre MF, Campanale MC, Montagna M, Saviano A, Hepato CATT Study Group for the Multidisciplinary Management of HCC, et al. Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma. Dig Liver Dis. 2015;47(3):242–8.

    Article  PubMed  Google Scholar 

  50. Wah TM, Arellano RS, Gervais DA, Saltalamacchia CA, Martino J, Halpern EF, et al. Image-guided percutaneous radiofrequency ablation and incidence of post-radiofrequency ablation syndrome: prospective survey. Radiology. 2005;237(3):1097–102.

    Article  PubMed  Google Scholar 

  51. Jansen MC, van Wanrooy S, van Hillegersberg R, Rijken AM, van Coevorden F, Prevoo W, et al. Assessment of systemic inflammatory response (SIR) in patients undergoing radiofrequency ablation or partial liver resection for liver tumors. Eur J Surg Oncol. 2008;34(6):662–7.

    Article  CAS  PubMed  Google Scholar 

  52. Lee S, Rhim H, Kim YS, Choi D, Lee WJ, Lim HK, et al. Percutaneous radiofrequency ablation of hepatocellular carcinomas: factors related to intraprocedural and postprocedural pain. AJR Am J Roentgenol. 2009;192(4):1064–70.

    Article  PubMed  Google Scholar 

  53. Seifert JK, France MP, Zhao J, Bolton EJ, Finlay I, Junginger T, et al. Large volume hepatic freezing: association with significant release of the cytokines interleukin-6 and tumor necrosis factor a in a rat model. World J Surg. 2002;26(11):1333–41.

    Article  PubMed  Google Scholar 

  54. Solbiati M, Muglia R, Goldberg SN, Ierace T, Rotilio A, Passera KM, et al. A novel software platform for volumetric assessment of ablation completeness. Int J Hyperthermia. 2019;36(1):337–43.

    Article  PubMed  Google Scholar 

  55. Livraghi T, Meloni F, Di Stasi M, Rolle E, Solbiati L, Tinelli C, et al. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? Hepatology. 2008;47(1):82–9.

    Article  PubMed  Google Scholar 

  56. Crocetti L, Bargellini I, Cioni R. Loco-regional treatment of HCC: current status. Clin Radiol. 2017;72(8):626–35.

    Article  CAS  PubMed  Google Scholar 

  57. ViettiVioli N, Duran R, Guiu B, Cercueil JP, Aubé C, Digklia A, et al. Efficacy of microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma in patients with chronic liver disease: a randomised controlled phase 2 trial. Lancet Gastroenterol Hepatol. 2018;3(5):317–25.

    Article  Google Scholar 

  58. Wu S, Hou J, Ding Y, Wu F, Hu Y, Jiang Q, et al. Cryoablation versus radiofrequency ablation for hepatic malignancies: a systematic review and literature-based analysis. Medicine. 2015;94(49):e2252.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Puijk RS, Ruarus AH, Vroomen LGPH, van Tilborg AAJM, Scheffer HJ, Nielsen K, COLLISION Trial Group, et al. Colorectal liver metastases: surgery versus thermal ablation (COLLISION)—a phase III single-blind prospective randomized controlled trial. BMC Cancer. 2018;18(1):821.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Han K, Ko HK, Kim KW, Won HJ, Shin YM, Kim PN. Radiofrequency ablation in the treatment of unresectable intrahepatic cholangiocarcinoma: systematic review and meta-analysis. J Vasc Interv Radiol. 2015;26(7):943–8.

    Article  PubMed  Google Scholar 

  61. Takahashi EA, Kinsman KA, Schmit GD, Atwell TD, Schmitz JJ, Welch BT, et al. Thermal ablation of intrahepatic cholangiocarcinoma: safety, efficacy, and factors affecting local tumor progression. Abdom Radiol. 2018;43(12):3487–92.

    Article  Google Scholar 

  62. Fairweather M, Swanson R, Wang J, Brais LK, Dutton T, Kulke MH, et al. Management of neuroendocrine tumor liver metastases: long-term outcomes and prognostic factors from a large prospective database. Ann Surg Oncol. 2017;24(8):2319–25.

    Article  PubMed  Google Scholar 

  63. Sofocleous CT, Nascimento RG, Gonen M, Theodoulou M, Covey AM, Brody LA, et al. Radiofrequency ablation in the management of liver metastases from breast cancer. Am J Roentgenol. 2007;189:883–9.

    Article  CAS  Google Scholar 

  64. Meloni MF, Andreano A, Laeseke PF, Livraghi T, Sironi S, Lee FT. Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation intermediate and long-term survival rates. Radiology. 2009;253:861–9.

    Article  PubMed  Google Scholar 

  65. Jakobs TF, Hoffmann RT, Schrader A, Stemmler HJ, Trumm C, Lubienski A, et al. CT-guided radiofrequency ablation in patients with hepatic metastases from breast cancer. Cardiovasc Interv Radiol. 2009;32:38–4695.

    Article  Google Scholar 

  66. Bonichon F, Buy X, Godbert Y, Pointillart V, de Figueiredo BH, Gangi A, et al. Local treatment of metastases from differentiated thyroid cancer. Ann Endocrinol. 2015;76(1 Suppl 1):1S40–6.

    Article  CAS  Google Scholar 

Download references

Funding

This study was not supported by any funding.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Laura Crocetti.

Ethics declarations

Conflict of interest

T. de Baére has received speaker honoraria from Medtronic and BTG and is a Grant recipient and has received speaker honoraria from Terumo. P. Pereira is a Grant recipient and has received speaker honoraria from Medtronic and Terumo Corporation and has received financial support from Angiodynamics. All other authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Crocetti, L., de Baére, T., Pereira, P.L. et al. CIRSE Standards of Practice on Thermal Ablation of Liver Tumours. Cardiovasc Intervent Radiol 43, 951–962 (2020). https://doi.org/10.1007/s00270-020-02471-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-020-02471-z

Keywords

Navigation